Home » Newsletters » BioWorld

BioWorld

June 30, 1993

View Archived Issues

GREENWICH RAISES $11.8 MILLION IN STOCK SALE

CALBIOCHEM MOVES ACTIVITIES

LILLY TAKES OVER CENTORX

MASOPROCOL REVERSES MULTIPLE DRUG RESISTANCE

HOTH JOINS CELL GENESYS

IMMUNOGEN BEGINS TRIALS

BROAD PROCESS PATENT FOR 'FORCED EVOLUTION'

PROTEIN POLYMER GRANTS LICENSE TO CELLCO

RECIPE FOR IMPROVING ON NATURE

COLLABORATION TO RESEARCH OSTEOPOROSIS

ID BIOMED TEAMS WITH TM TECHNOLOGIES

HEMACARE REGISTRATION DECLARED EFFECTIVE

TRANSDERMAL GLUCOSE MONITORING PATENT ALLOWED

CELLEX DISTRIBUTION PACT WITH TOSOH

BTG'S GROWTH HORMONE LAUNCHED IN JAPAN

BRITISH BIO RESTRUCTURES RELATIONSHIP WITH TECHNE

RAC APPROVES AIS GENE THERAPY PROTOCOL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...